JY
ALLR

Jeff Yass’s Allarity Therapeutics ALLR Stock Holding History

Jeff Yass’s Portfolio ALLR Stock Details ALLR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.2K Buy
+17,221
New +$24.4K ﹤0.01% 13020

Other funds holding ALLR

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MCM
Militia Capital Management Austin, Texas $3.37B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Jeff Yass's ALLR Position: Q2 2026 in Review

Jeff Yass opened a new position in Allarity Therapeutics (ALLR) in Q2 2026: 17,221 shares worth $22.2K. The stake represents ﹤0.01% of the portfolio and ranks #13020 among its holdings.

20 funds tracked by Wall St. Rank hold ALLR as of Q2 2026.

  • Jeff Yass held 17,221 shares of Allarity Therapeutics worth $22.2K as of Q2 2026.
  • Allarity Therapeutics was a new Jeff Yass position in Q2 2026.
  • Allarity Therapeutics made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #13020 holding.
  • 20 funds tracked by Wall St. Rank held Allarity Therapeutics as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.